Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
16,681,212
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
2,822,037
-
Shares change
-
+1,405,683
-
Total reported value, excl. options
-
$20,644,859
-
Value change
-
+$10,288,104
-
Number of buys
-
14
-
Number of sells
-
-2
-
Price
-
$7.41
Significant Holders of Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) as of Q4 2023
20 filings reported holding COYA - Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Coya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (COYA) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,822,037 shares
of 16,681,212 outstanding shares and own 16.92% of the company stock.
Largest 10 shareholders include GREENLIGHT CAPITAL INC (1,274,026 shares), AIGH Capital Management LLC (1,031,977 shares), CM Management, LLC (100,000 shares), VANGUARD GROUP INC (97,152 shares), Worth Venture Partners, LLC (92,667 shares), GEODE CAPITAL MANAGEMENT, LLC (92,465 shares), PRELUDE CAPITAL MANAGEMENT, LLC (35,770 shares), BlackRock Inc. (21,775 shares), Potomac Capital Management, Inc. (21,101 shares), and CITADEL ADVISORS LLC (16,592 shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.